StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)

Close on Nov 18, 2026Market cap $59.59MP/E –Yield –

Lensar operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Lensar's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.29M. For fiscal 2025 it was -$14.83M. The highest annual figure on record is -$2.28M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.83M–
FY2024Dec 31, 2024-$2.28M–
FY2023Dec 31, 2023-$9.66M–
FY2022Dec 31, 2022-$14.86M–
FY2021Dec 31, 2021-$8.97M–
FY2020Dec 31, 2020-$13.79M–
FY2019Dec 31, 2019-$12.59M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$127.00K–
Q1 FY2026Mar 31, 2026-$4.27M–
Q4 FY2025Dec 31, 2025$618.00K-83.1%
Q3 FY2025Sep 30, 2025-$3.51M-211.4%
Q2 FY2025Jun 30, 2025-$5.00M–
Q1 FY2025Mar 31, 2025-$6.94M–
Q4 FY2024Dec 31, 2024$3.66M–
Q3 FY2024Sep 30, 2024$3.15M–
Q2 FY2024Jun 30, 2024-$3.78M–
Q1 FY2024Mar 31, 2024-$5.31M–
Q4 FY2023Dec 31, 2023-$480.00K–
Q3 FY2023Sep 30, 2023-$339.00K–
Q2 FY2023Jun 30, 2023-$2.14M–
Q1 FY2023Mar 31, 2023-$6.70M–
Q4 FY2022Dec 31, 2022-$4.76M–
Q3 FY2022Sep 30, 2022-$4.70M–
Q2 FY2022Jun 30, 2022-$2.79M–
Q1 FY2022Mar 31, 2022-$2.61M–
Q4 FY2021Dec 31, 2021-$739.00K–
Q3 FY2021Sep 30, 2021-$2.15M–
Q2 FY2021Jun 30, 2021-$1.46M–
Q1 FY2021Mar 31, 2021-$4.62M–
Q4 FY2020Dec 31, 2020-$2.00M–
Q3 FY2020Sep 30, 2020-$55.00K–
Q2 FY2020Jun 30, 2020-$5.38M–
Q1 FY2020Mar 31, 2020-$6.36M–
Q4 FY2019Dec 31, 2019-$6.78M–

More Lensar figures

See a number that looks wrong?